Reporter brief
Effect of Rapamycin in Ovarian Aging
What happened
Trial registry update: ACTIVE_NOT_RECRUITING. No results reported in the supplied registry record.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- This abstract does not report any human findings and therefore does not establish whether rapamycin affects ovarian aging in women
- The study's design, sample size, primary outcome, and actual results are not described in the abstract provided
- No comparison of rapamycin to placebo outcomes is presented
Study design and sample
Rct; Human.
Women
- Design
- Rct
- Sample
- —
- Journal
- Columbia University
- Published
- Dec 26, 2025
Effect size
Not recorded.
Caveats
- Assessment: Unassessed.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Rapamycin timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.